Combinent BioMedical Systems is an early-stage medical device company developing a transvaginal polymer drug delivery platform. This novel platform promises to greatly improve treatment of a number of women’s health diseases with large markets and high unmet needs, including those prevalent in the developing world. The company’s founders are Dr. Robert Langer, Professor of Chemical Engineering at MIT, and Dr. William Crowley, Chief of the Reproductive Endocrine Unit of the Department of Medicine at Massachusetts General Hospital.
Location: Cambridge, Massachusetts
Commons Capital’s co-investors include:
VIMAC Ventures and Cytyc Corporation (Nasdaq: CYTYC)